Genetics play a role in the development of many health conditions ... Researchers are increasingly attempting to work around ...

Aliso Viejo-based Ambry Genetics Corp. on Nov. 4 announced an agreement to be acquired for $600 million by Tempus AI Inc.

University of Wisconsin–Madison researchers are warning that artificial intelligence tools gaining popularity in the fields ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

With Ambry Genetics in tow, Eric Lefkofsky's biotech startup hopes to accelerate its drive toward turning a profit.

Aliso Viejo-based Ambrey Genetics Corp., Orange County’s third-largest medical diagnostics and testing company, has entered ...

Tempus AI said it agreed to pay $375 million in cash and $225 million in shares to acquire genetic testing company Ambry Genetics. Ambry conducts hereditary cancer screening and currently serves as ...

Tempus announced that it has entered into an agreement to acquire Ambry Genetics, a leader in genetic testing. Under the terms of the ...

Konica Minolta (JP:4902) has released an update. Konica Minolta has announced the sale of its subsidiary, Ambry Genetics, to Tempus AI, as part ...

Accenture (NYSE: ACN) has invested, through Accenture Ventures, in 1910 Genetics (or “1910”), a biotechnology company advancing small and large molecule drug discovery with a multimodal AI ...

Tempus AI Inc (TEM) reports a 33% revenue increase and announces the acquisition of Ambry Genetics to enhance its genomic capabilities.